Previous Close | 12.53 |
1-Year Change | -30% |
6-Months Change | -44.34% |
3-Months Change | 5.47% |
Moving Avg (50d) | 12.511 |
Moving Avg (200d) | 15.718 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.618B |
Beta (3-Years) | 1.28 |
Revenue Growth (ttm) | -8.18% |
Net Profit Margin (ttm) | -270.74% |
Return On Assets (ttm) | -42.34% |
EPS (ttm) | -1411.7 |
PE Ratio (ttm) | -0.01 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |